HealthQuill Apellis Pharmaceuticals
The US Food and Drug Administration has approved Apellis Pharmaceuticals, Inc.’s medicine for treating two rare and serious kidney diseases.
Drugs Health Pharma

FDA approves Apellis’ therapy to treat two serious, rare kidney diseases

HQ Team July 30, 2025: The US Food and Drug Administration has approved Apellis Pharmaceuticals, Inc.’s medicine for treating two rare and serious.

Read More
Apellis Pharmaceuticals, a US-based biopharmaceutical company, has got FDA approval for a drug to treat geographic atrophy, the company announced.
Drugs Medical Pharma

FDA gives nod for Apellis’ injection to treat geographic atrophy

Apellis Pharmaceuticals, a US-based biopharmaceutical company, has got FDA approval for a drug to treat geographic atrophy, the company announced.

Read More